Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Walking 8,500 steps daily may help prevent weight regain

10

May 2026

Walking 8,500 steps daily may help prevent weight regain

New research being presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) and published in International Journal of Environmental Research and Public Health shows that doing around 8,500 steps a day can help people keep weight off after dieting.

Non-invasive swab test offers fast, accurate tuberculosis detection worldwide

10

May 2026

Non-invasive swab test offers fast, accurate tuberculosis detection worldwide

A portable molecular test, MiniDock MTB, detected pulmonary tuberculosis rapidly and accurately across seven high-burden countries, using sputum or tongue swab samples. The study suggests the low-cost, battery-operated platform could expand near-point-of-care TB diagnosis in low-resource settings, although real-world implementation and drug-resistance integration still need evaluation.

Do repeated football head hits disrupt the gut microbiome?

10

May 2026

Do repeated football head hits disrupt the gut microbiome?

A small exploratory study of collegiate football players found that non-concussive head impacts are correlationally linked to acute and season-long shifts in gut microbiome composition, with changes most pronounced 48–72 hours after significant impacts. However, most associations weakened after correction for multiple testing, and the authors stress the findings are preliminary and hypothesis-generating.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.